Project NEUROBOT is one of 18 sharing £69m over four years in new funding announced yesterday (January 20, 225) from ARIA’s Precision Neurotechnologies programme. The NEUROBOT team will work to develop advanced, injectable neural robots, or ‘neurobots’, to deliver a treatment called closed-loop neuromodulation as an epilepsy treatment. Closed-loop neuromodulation works by closely monitoring brain
Introduction Cervical carcinoma is one of the most common gynecological cancers worldwide, accounting for approximately 12% of all carcinomas in women.1 It originates from abnormal cell growth in the cervix and has the potential to invade or metastasize to other parts of the body. In the early stages, cervical carcinoma often presents no noticeable symptoms,
publication date: Jan 20, 2025 | author/source: Abselion Ruizhi Wang, CEO, Abselion with the Amperia at-line protein analyser. Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market. This cutting-edge benchtop instrument allows scientists to easily quantify
Washington: Scientists at the University of Stuttgart have succeeded in controlling the structure and function of biological membranes with the help of ‘DNA origami‘. It will help in facilitating the transportation of large therapeutic loads into cells. It now paves a new way for the targeted administration of medication and other therapeutic inventions. The team
Washington [USA], January 19 (ANI): Scientists at the University of Stuttgart have succeeded in controlling the structure and function of biological membranes with the help of ‘DNA origami’. It will help in facilitating the transportation of large therapeutic loads into cells. It now paves a new way for the targeted administration of medication and other